REPLAGAL conc perf 3.5 mg/3.5ml flac 3.5 ml
7680557740012
CH-55774
A16AB03
07.14.0.
1 / 3
google
Details
- Product number
- 5577401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- agalsidasum alfa 1 mg, natrii dihydrogenophosphas monohydricus, polysorbatum 20, natrii chloridum, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.1 mg.
Articles (1)
Replagal Durchstechflasche à 3.5 mL, Infusionskonzentrat
Infusionskonzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.1 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1960.85
Specialties list
Yes
Generic
No
SL addition date:
01/07/2002
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 55774
- Drug name
- Replagal, Infusionskonzentrat
- Galenic form
- KOINF
- ATC Code
- A16AB03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/12/2001
- Authorization expiration date
- 31/12/9999
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REPLAGAL conc perf 3.5 mg/3.5ml flac 3.5 ml
- Description (DE)
- REPLAGAL Inf Konz 3.5 mg/3.5ml Durchstf 3.5 ml
- Market launch
- 28/12/2001
- Narcotic (BTM)
- No